Medicare Begins Negotiating Prescription Drug Prices
Published Date: 6/16/2026
Proposed Rule
Summary
Starting soon, Medicare will negotiate drug prices to help lower costs for people who rely on prescription drugs. This change affects Medicare users and drug companies, aiming to make medicines more affordable by 2026. The program also updates rules about combined drugs, so everyone gets better deals and clearer benefits.
Analyzed Economic Effects
7 provisions identified: 4 benefits, 1 costs, 2 mixed.
Medicare spending shifts through 2031
CMS states the Inflation Reduction Act's effects will reduce government expenditures for Medicare Part B, increase Part D expenditures through 2030, and decrease Part D expenditures beginning in 2031. These spending shifts reflect the program's phased fiscal impacts across the years described.
Medicare begins drug price negotiations
Medicare is negotiating maximum fair prices (MFPs) for certain high-expenditure, single-source drugs. The Secretary selected 10 drugs for the first year and the negotiated prices for those drugs took effect in initial price applicability year 2026.
Annual drug selections expand to 20
Beginning with initial price applicability year 2029, the Secretary may select up to 20 drugs covered under Part D and/or payable under Part B for negotiation each year. CMS proposes that selection and negotiation processes for 2029 will occur during calendar year 2027.
Temporary floor for small biotech drugs
CMS proposes rules to implement a Temporary Floor for Small Biotech Drugs for initial price applicability years 2029 and 2030 and includes a definition for eligible Small Biotech Drugs. CMS will explain the process for a Primary Manufacturer to request consideration for this Temporary Floor.
Small biotech exclusion ended in 2028
CMS notes that the exclusion for small biotech drugs from negotiation eligibility ended in initial price applicability year 2028 and therefore is not codified in this rule. The proposed rule nevertheless includes a definition for Small Biotech Drug to support the Temporary Floor calculation.
Renegotiation authority begins in 2028
Starting with initial price applicability year 2028, CMS may determine drugs eligible for renegotiation and may select drugs for renegotiation of their MFPs. The Secretary selected one drug for renegotiation for initial price applicability year 2028.
Fixed-combination drug policy modified
CMS proposes a narrow modification to the fixed combination drug policy for certain new formulations: if products from the same NDA/BLA holder differ because a new active ingredient enables an alternative route of administration, CMS will identify the potential qualifying single source drug using all dosage forms and strengths offered by that NDA/BLA holder. This changes how certain combination products may be treated for negotiation eligibility.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-12069 — Medicare Program; Strengthening Oversight of Accrediting Organizations (AOs) and Preventing AO Conflicts of Interest, and Related Provisions
This new rule makes sure the groups that check Medicare providers play fair and follow clear rules to avoid conflicts of interest. It updates how psychiatric hospitals are reviewed and tightens rules for providers who lost their Medicare status but want back in. These changes affect Medicare providers and accrediting groups, start June 16, 2027, and aim to keep care safe and trustworthy.
2026-10890 — Medicare Program; Alternative Payment Model Updates and the Increasing Organ Transplant Access (IOTA) Model
Starting July 1, 2026, Medicare is updating the Increasing Organ Transplant Access (IOTA) Model to help kidney transplant hospitals do even better at getting more people transplanted and improving care quality. These changes affect hospitals involved in kidney transplants and aim to make the process smoother and more effective, with new payment rules that reward success. This update is part of a 6-year plan running through 2031 to save more lives and boost patient experience.
2026-10292 — Medicaid Program; Medicaid Managed Care State Directed Payments and Medicaid Fee-for-Service Targeted Medicaid Practitioner Payments
This proposed rule changes how states can pay Medicaid managed care plans and certain doctors to make sure payments are fair, efficient, and encourage enough providers to offer quality care. It affects states, Medicaid managed care organizations, and targeted Medicaid practitioners, aiming to keep payments balanced and services available. Comments on these changes are open until July 21, 2026, so stakeholders have time to weigh in before it’s finalized.
2026-10050 — Patient Protection and Affordable Care Act, HHS Notice of Benefit and Payment Parameters for 2027; and Basic Health Program
Starting in 2027, health insurance plans on federal and state marketplaces will see new rules to make coverage fairer and easier to use. These changes affect insurance companies, agents, and people buying plans, including new fees, penalties, and better protections for those with hardships. Expect updates on plan quality, dental coverage limits, and longer-term catastrophic plans, all aiming to keep your health coverage solid and affordable.
2026-07205 — Medicare and Medicaid Programs; Patient Protection and Affordable Care Act; Interoperability Standards and Prior Authorization for Drugs for Medicare Advantage Organizations, Medicaid Managed Care Plans, State Medicaid Agencies, Children's Health Insurance Program (CHIP) Agencies and CHIP Managed Care Entities, and Issuers of Qualified Health Plans on the Federally-Facilitated Exchanges
This new rule will help Medicare, Medicaid, CHIP, and health plan companies share patient info more easily and speed up drug approval requests. It affects Medicare Advantage, Medicaid, CHIP, and health plans on federal exchanges, aiming to make care smoother and faster. These changes will start soon and could save time and money by cutting red tape.
2026-04797 — Medicare and Medicaid Programs; CY 2026 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings Program Requirements; and Medicare Prescription Drug Inflation Rebate Program; Correction
This document fixes some typos and technical mistakes in the Medicare and Medicaid payment rules for 2026. It affects doctors, healthcare providers, and anyone using Medicare Part B by clarifying payment policies and program requirements starting January 1, 2026. These corrections help make sure payments and coverage rules are clear and accurate, so everyone gets paid right and on time.
Previous / Next Documents
Previous: 2026-12054 — Drawbridge Operation Regulation; Wishkah River, Aberdeen, WA
The Coast Guard wants to change how the Puget Sound and Pacific railroad bridge over the Wishkah River in Aberdeen, WA operates. Since boats rarely need the bridge to open—only once or twice a year—the bridge will stay closed by default and only open if boaters give 24 hours’ notice. This means no more full-time bridge operator needed, saving time and money for the bridge owner and making things smoother for everyone.
Next: 2026-12100 — Technical Amendments: Special Financial Assistance
The Pension Benefit Guaranty Corporation is updating rules about special financial help for pension plans. These changes clarify how plans can invest the money, when PBGC approval is needed for certain claims, and remove a rule about using funds for health costs. Plan managers and employers should note these tweaks and send comments by August 17, 2026.